Part of the USC/CHLA Cell Therapy Program Seminar Series

Join us and actively participate in the discussion! 

  • Identifying an appropriate development strategy for cell therapy products 
  • Outlining expected evidence that should be collected on a cell therapy candidate to satisfy regulatory requirements
  • Addressing frequent challenges facing investigators during the development of cell therapies 

with Mohamed Abou-el-Enein, MD, PhD, MSPH
Associate Professor of Clinical Medicine, Pediatrics, and Stem Cell Biology & Regenerative Medicine
Executive Director, Joint USC/CHLA Cell Therapy Program

and Magdi Elsallab, MD
Regulatory Affairs and Clinical Development Specialist, Joint USC/CHLA Cell Therapy Program


Event Details

0 people are interested in this event

User Activity

No recent activity